STOCK TITAN

Longevity Health - XAGE STOCK NEWS

Welcome to our dedicated page for Longevity Health news (Ticker: XAGE), a resource for investors and traders seeking the latest updates and insights on Longevity Health stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Longevity Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Longevity Health's position in the market.

Rhea-AI Summary

Longevity Health Holdings (NASDAQ: XAGE) has announced a merger agreement with 20/20 BioLabs in an all-stock transaction valued at approximately $99 million. The merger is expected to double Longevity's fiscal year 2025 revenue from $3-4 million to $7-8 million, with anticipated operational savings of over $1 million.

20/20 BioLabs operates a CLIA Licensed, CAP Accredited lab and offers OneTest™, a multi-cancer early detection blood test for over a dozen tumor types at under $200. The company has integrated its testing into routine evaluations for firefighters and military veterans, and plans to launch a longevity test in Spring 2025.

Post-merger, the combined company will continue trading under XAGE, with Jonathan Cohen appointed as CEO while Rajiv Shukla remains Chairman. The merger advances Longevity's strategy in diagnostics and synergizes with its bio-aesthetic portfolio under the banner "Healthy Aging, Inside and Out™".

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
63.72%
Tags

FAQ

What is the current stock price of Longevity Health (XAGE)?

The current stock price of Longevity Health (XAGE) is $0.1562 as of April 18, 2025.

What is the market cap of Longevity Health (XAGE)?

The market cap of Longevity Health (XAGE) is approximately 3.8M.
Longevity Health

Nasdaq:XAGE

XAGE Rankings

XAGE Stock Data

3.75M
23.98M
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
PITTSBURGH